1. Home
  2. KRRO

as of 12-18-2025 3:57pm EST

$7.86
$0.05
-0.63%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Chart Type:
Time Range:
Founded: 2014 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 58.6M IPO Year: 2019
Target Price: $74.17 AVG Volume (30 days): 443.1K
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -9.42 EPS Growth: N/A
52 Week Low/High: $5.20 - $55.89 Next Earning Date: 11-12-2025
Revenue: $7,371,000 Revenue Growth: N/A
Revenue Growth (this year): 144.83% Revenue Growth (next year): -59.55%

AI-Powered KRRO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 80.00%
80.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: